Dr. Arianna Bassan, PhD in Chemical Physics, is a European Registered Toxicologist (ERT) and chartered chemist. With international experience at Stockholm University, MSD/Merck&Co., and the European Commission, she co-founded Innovatune, specializing in human health hazard assessment through the combination of traditional toxicology and AI-driven in silico tools.She has led global expert networks, including industry collaborations for example onweight-of-evidence approach for carcinogenicity assessment. Her collaboration with health authorities underscores her contributions to regulatory science. She has authored numerous toxicity reports and peer-reviewed articles.

Dr. Andreas M Papas is Adjunct Professor of the College of Medicine, East Tennessee State University and CEO and member of the Board of Directors of Antares Health Products, Inc. A Fulbright Scholar, Dr. Papas is a graduate of the University of Illinois and author of The Vitamin E Factor paperback and editor of the scientific book Antioxidant Status, Diet, Nutrition and Health. Dr Papas developed product concepts and managed formulation, clinical evaluation supported by the National Institutes of Health and the Cystic Fibrosis Foundation, stability and safety testing, pilot, and commercial production.

Dr. Claudia Cusan was born nearby Venice (Italy), and completed her master's and doctoral degrees in Pharmaceutical Chemistry at the University of Trieste (Italy). After the PhD, she moved to the Netherlands, where she worked in the pharmaceutical business unit of Royal DSM, first as R&D scientist and then as project manager. Her research focused on the development of new chemo-enzymatic strategies for the synthesis of generics APIs, and the preparation of new biomaterials for medical devices. Then she registered as European Toxicologist and became Global Corporate Toxicologist at Royal DSM, with global responsabilities for the company strategy in the area of toxicology and product safety. In 2017 she returned to Italy, where she founded S&C BEST Srl, a consultancy compay specialized in toxicology, supporting firms active in different sector as: pharmaceutical products, cosmetic formulations, medical devices, food contact materials, polymers. In 2023 S&C BEST Srl earned the membership of the Corporate Program at Eurotox. Dr. Claudia Cusan is member of Italian Association Business Operators in Food Contact Material (AIBO), and member of External Committee of the master’s degree in Pharmaceutical Chemistry at University of Trieste.

Rassa Pegahi holds a Ph.D. in Molecular and cell Biology and brings extensive of hands-on experience in oncology from a hospital environment before joining the pharmaceutical industry. Currently, Dr. Pegahi is pursuing her career in the pharmaceutical industry as a specialist in medical affairs & clinical trials.

Professor of Toxicology in Drug Discovery and Development at the Technical University of Kaiserslautern, Germany, with over 30 years of experience in the pharmaceutical industry. He has held significant roles at Novartis and Janssen (JNJ), focusing on mechanistic and investigative toxicology. A board-certified toxicologist, he has served as a scientific advisor and board member for various international organizations. Prof. Wolf co-founded and served as interim CEO of TransHeps AG and was the Chief Scientific Officer (CSO) at InSphero, a leading company in 3D-cell-based organ-on-a-chip technology and microphysiological systems (MPS). He is a respected leader in industrial in vitro toxicology, particularly in Drug-induced Liver Injury (DILI)

Dr. Eugene Zadorin is a highly accomplished expert with over 20 years of experience addressing toxicological challenges through innovative research and applied solutions. He holds a PhD and has devoted his career to advancing biotechnological approaches for evaluating and mitigating the toxicological risks of pharmaceuticals, industrial compounds, and environmental agents. His work bridges pharmacology and toxicology, with a focus on drug safety, biomarker development, and the creation of advanced biotechnological platforms for toxicity testing. His research has contributed significantly to the understanding of molecular mechanisms underlying adverse drug reactions and environmental exposures. As a leader in his field, he has authored more than 50 peer-reviewed publications and book chapters and has presented his findings at major international conferences. He serves as an advisor to regulatory bodies and industry stakeholders, helping shape strategies for safer drug development and sustainable biotechnological practices. Currently, he is the Director of a cutting-edge research laboratory, where he leads a multidisciplinary team in tackling toxicological problems through biotechnological innovation. He is also committed to mentoring young scientists and fostering global collaborations to advance health and safety in the pharmacological and biotechnological sciences.

Dr. Suzanne Fitzpatrick is the Senior Advisor for Toxicology at the US Food and Drug Administration Foods Program. She is a board-certified toxicologist in the US and in Europe. Dr. Fitzpatrick chairs the FDA’s Alternative Methods Work Group thatis currently focusing on in vitroMicrophysiologicalSystems.Dr. Fitzpatrick helped develop the FDA DARPA NCATS program on Organs on a Chip and continues to work and give presentations on this evolving area. .Dr. Fitzpatrick co-chairs with EFSA the International Working Group on New Approach Methods for Food Safety under the International Liaison Group on Methods for Risk Assessment in Food, a coalition of food safety regulatory from over 29 countries and organizations.. She is on the International Regulatory Board for the EU APSIS (Risk Hunter, Precision Toc, Ontox) Research Collaboration for developing new non- animal methods. She is the FDA representative to PARC- The European Collaboration for Chemical Risk Assessment. She is on the Board of Directors for the International MPS Society. Dr. Fitzpatrick is the FDA lead and co-chair for ICCVAM and for Tox 21. She received her BA from the University of California at San Diego and her PhD from Georgetown University.

A Szczecin University of Technology graduate, she completed her Master's degree in chemical and process engineering. Actually she has worked with the West Pomeranian University of Technology in Szczecin, Poland. She earned a Ph.D. in agricultural sciences in food technology and human nutrition, specializing in toxicology, in 2004, and an habilitation in 2013. Since 2020, she has been the Director of the Department of Toxicology, Dairy Technology, and Food Storage. Her research focuses on food safety, toxicology, and environmental ecotoxicology, using advanced chromatography techniques. She is a prolific author and reviewer in scientific journals and conferences and is a coauthor of projects for business entities. - Testing the presence of chemical contaminants (heavy metals, pesticides, PCBs, PAHs, etc.) in food, drinks, and drinking water, taking into account their sources (environment, processing, packaging, transport, storage), - examine the impact of technological processing and culinary treatments on the level of chemical contaminants in final food products in terms of the possibility of reducing it; - testing for the presence of natural toxic substances, - research on the circulation of xenobiotics in aquatic and terrestrial ecosystems (movement in the soil, plant, animal, water, sediment, organisms system), including monitoring the contamination of abiotic elements of the aquatic environment and hydrobionts with heavy metals, pesticides, PCBs, PAHs and other compounds, - Study of the dynamics of bioaccumulation, excretion, and detoxification of xenobiotics in aquatic organisms and the effects of poisoning of aquatic organisms

Ilya B. Tsyrlov, MD, has completed his PhD in Biochemistry at the age of 27, and thereafter – a higher degree Doctor of Science in Molecular Pharmacology. He has been working as Head of the laboratory, Department Chair at Russian Academy of Science. In the United States, Tsyrlov served a Senior Research Fellow at NCI/NIH, and a Research Professor at Mount Sinai School of Medicine. Since 2005, a President/CSO of the XENOTOX, Inc, USA. Incepted and developed the Xenovirology, an interdisciplinary biomedical field, and prioritized modifications of analgesics, synthetic opioids and antimalarials thus developing long-acting drug delivery formulations. He is the author of 6 monographs and 300+ peer reviewed publications, and has been serving as an editorial board member of repubted journals.

Dr. Wei Wu serves as Deputy Dean of the School of International Education, Deputy Director of the Department of International Cooperation and Exchange, Professor of the Department of Toxicology at Nanjing Medical University, China. He was a guest researcher at the National Institute of Environmental Health Sciences (NIEHS) between 2017 and 2018. He is the PI of the State Key Laboratory of Reproductive Medicine andOffspring Health, and the Key Laboratory of Modern Toxicology of the Ministry of Education. He is a member of different national and international societies in the fields of human reproduction and toxicology, and has received awards from many national societies for the originality and quality of his projects. He has a wide range of teaching and consulting experience, including in toxicology. His research interests include the application of new media technology in teaching, epigenetic mechanisms of transgenerational effects of male infertility induced by endocrine disrupting chemicals, environmental exposure and male reproductive health, genetic and epigenetic risk factors of male infertility and abnormal fetal growth.

Dr. Slimane Belbraouet received his Ph.D. from the Université de Nancy (France) in 1994. He did his Postdoctoral Fellowship in 1995 at the Center of Human Nutrition and INSERM U420 (Nancy, France), Professor Belbraouet started his academic career in 1980 and is currently a full professor at the School of Nutrition (Université de Moncton, Canada) teaching both undergraduate and graduate levels and covering many aspects of nutrition: Nutrition & metabolism, Nutrition through the life cycle, research methods, Nutrition and health... He is internationally recognized for his research expertise in food science, the promotion of healthy eating, and the etiology of nutrition-related diseases.

Dr. Tuğçe Uskur was born in Istanbul, Turkey, and completed her master's and doctoral degrees in Medical Pharmacology at the Cerrahpaşa Faculty of Medicine. She is currently serving as an Assistant Professor in the Department of Medical Pharmacology at Kırklareli University Faculty of Medicine. Dr. Uskur's research interests include pharmacology, psychopharmacology, toxicology, and pharmacotherapies in emergency medicine, with a particular focus on drug interactions and the clinical impacts of drug levels. She has contributed to national and international journals and has presented at various conferences and seminars. Dr. Uskur is actively engaged in research on common poisonings and treatment methods in emergency services, making significant contributions to these fields and participating in numerous scientific projects. Additionally, she is actively involved in the education of students, emphasizing the training of the next generation of health professionals.

Research, Technology, Engineering, Innovation and Business Consulting. OVER 20 YEARS OF EXPERIENCE WITH ADMINISTRATION AND MANAGEMENT OF PUBLIC AND PRIVATE COMPANIES. OVER 25 YEARS OF EXPERIENCE WITH COMPUTING AND DATA ANALYSIS. Currently, he is an ASSOCIATE PROFESSOR 4 at the Federal University of Rondônia: Professor of the Department of Electrical Engineering and Professor / Researcher of the Postgraduate Program: Doctorate / Master in Regional Development and Environment (PGDRA / UFRO). He has a degree in Mathematics from UFMT (2000), PHYSICS - Law no. 13.691 / 2018, Specialization in Physics - UFMT (2001), Specialization in in Computer Networks - UNIRONDON (2009), Master in Physics from the Federal University of Ceará (2002) and PhD in Physics from UFC (2005), Post-doctorate - UFMT / CNPq (2009). They have scientific research with themes of Exact Sciences, Engineering and Computing; Modeling, Management, Technology, Innovation and Regional Development.

Prof. Bechan Sharma is presently working as a Professor and Head, Department of Biochemistry, and Dean, Faculty of Science, University of Allahabad, Allahabad, India. He has completed his higher education such as B.Sc. (Honours)-1980; M.Sc. (Biochemistry)-1982 and Ph.D. in Biochemistry (1988) from BHU-Varanasi. The areas of his research interest include Molecular Biology of HIV/AIDS, Free radical Biology, Tropical Diseases (Filariasis/Malaria), Enzyme technology, Drug development and Biochemical Toxicology. He has received number of Awards/ Honors and successfully completed numerous important Academic/ Administrative Assignments. He has 36 years of teaching / research experience. He has carried out several research projects and published over 230 research papers including book chapters, molecular methods in peer reviewed International and National Journals of repute. He has one US patent on HIV-1 genome structure based antiHIV-1 drugs design to his credit. He has supervised 18 PhDs and 7 PDFs.

Prof. D. K. Dhawan is presently working as a Professor Emeritus in the department of Biophysics and has previously worked as Professor of Biophysics for 15 years. He also founded the Centre for Nuclear Medicine at Panjab University, Chandigarh in the year 2006 and headed the same for 9 years and was also Coordinator, Centre for Medical Physics in the year 2013. Professor Dhawan did his Ph.D. from Post Graduate Institute of Medical Education & Research, Chandigarh, India in the year 1984. Prior to his Ph.D., he worked in Radiation Medicine Centre of Bhabha Atomic Research Centre, Mumbai, India, and was awarded Post Graduate Diploma in Medical Radioisotopes Techniques in the year 1978. His research areas are radiation medicine, toxicology and cancer. He has published 233 research articles and 189 are listed in Scopus during 38 years of his research career.